CD79A and nasopharyngeal carcinoma: Notably, elevated serum IgA levels indicate continuous exposure to EBV and serve as high-risk biomarkers of NPC, whereas elevated titers of EBV neutralizing antibodies and anti-gp350 antibodies are considered low-risk biomarkers for NPC.